Skip to main content

Redmile Group, LLC

SEC CIK
0001425738
Latest filing
Aug 14, 2026

NGNE holding history

Neurogene Inc. in every 13F filed by Redmile Group, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

NGNE overviewAll 13F holders of NGNEFull Q2 2026 holdings

Shares (Q2 2026)
1,412,199
Value
$44.4M
% of portfolio
3.0%
Quarters held
22
Since Q1 2021
Holdings of NGNE by Redmile Group, LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20261,412,199$44.4M3.0%−47,400−3.2%ReducedHolders
Q1 20261,459,599$29.4M1.9%00.0%UnchangedHolders
Q4 20251,459,599$30.1M2.2%+160,577+12.4%AddedHolders
Q3 20251,299,022$22.5M2.2%+22,346+1.8%AddedHolders
Q2 20251,276,676$19.1M2.0%−31,387−2.4%ReducedHolders
Q1 20251,308,063$15.3M1.4%−11,700−0.9%ReducedHolders
Q4 20241,319,763$30.2M2.1%+355,416+36.9%AddedHolders
Q3 2024964,347$40.5M2.4%−49,316−4.9%ReducedHolders
Q2 20241,013,663$36.9M2.2%+78,411+8.4%AddedHolders
Q1 2024935,252$47.6M1.7%−11,645−1.2%ReducedHolders
Q4 2023946,897$18.4M0.7%+801,286+550.3%AddedConverted for a 1-for-4 splitHolders
Q3 2023582,443$2.30M0.1%00.0%UnchangedConverted for a 1-for-5 splitHolders
Q2 20232,912,228$2.42M0.1%+1,064,628+57.6%AddedHolders
Q1 20231,847,600$1.29M0.1%−2,966−0.2%ReducedHolders
Q4 20221,850,566$941.9K<0.1%−1,586,369−46.2%ReducedHolders
Q3 20223,436,935$2.20M0.1%00.0%UnchangedHolders
Q2 20223,436,935$3.54M0.1%−28,500−0.8%ReducedHolders
Q1 20223,465,435$6.51M0.2%−25,400−0.7%ReducedHolders
Q4 20213,490,835$16.8M0.4%−16,400−0.5%ReducedHolders
Q3 20213,507,235$25.4M0.4%−412,000−10.5%ReducedHolders
Q2 20213,919,235$36.2M0.5%−198,334−4.8%ReducedHolders
Q1 20214,117,569$50.7M0.7%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.